|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400082603 |
|
最近更新日期: Date of Last Refreshed on: |
2024-04-01 17:25:41 |
|
注册时间: Date of Registration: |
2024-04-01 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
数字疗法轻度认知障碍患者居家康复训练试验 |
|
Public title: |
Digital-based Cognitive-Physical Exercise for Mild Cognitively Impaired Individuals Training at Home |
|
注册题目简写: |
数字疗法认知和体能训练 |
|
English Acronym: |
Digital-Cog-PE |
|
研究课题的正式科学名称: |
数字疗法在轻度认知障碍患者居家康复中的应用与评价 |
|
Scientific title: |
Application and effectiveness of digital therapy in home-based rehabilitation of patients with mild cognitive impairment |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
丁金东 |
研究负责人: |
丁金东 |
|
Applicant: |
Jingdong Ding Petersen |
Study leader: |
Jingdong Ding Petersen |
|
申请注册联系人电话: Applicant telephone: |
+86 132 5640 6001 |
研究负责人电话: Study leader's telephone: |
+86 132 5640 6001 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
dingjindong@hainmc.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
dingjindong@hainmc.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
海南省海口市龙华区学院路3号 |
研究负责人通讯地址: |
海南省海口市龙华区学院路3号 |
|
Applicant address: |
No. 3, Xueyuan Road, Longhua District, Haikou City, Hainan Province, China |
Study leader's address: |
No. 3, Xueyuan Road, Longhua District, Haikou City, Hainan Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
571199 |
研究负责人邮政编码: Study leader's postcode: |
571199 |
|
申请人所在单位: |
海南医学院 |
||
|
Applicant's institution: |
Hainan Medical University |
||
|
研究负责人所在单位: |
海南医学院 |
||
|
Affiliation of the Leader: |
Hainan Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
HYLL-2023-446 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
海南医学院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Hainan Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-09-27 00:00:00 |
||
|
伦理委员会联系人: |
傅文丽 |
||
|
Contact Name of the ethic committee: |
Wenli Fu |
||
|
伦理委员会联系地址: |
海南省海口市龙华区学院路3号 |
||
|
Contact Address of the ethic committee: |
No. 3, Xueyuan Road, Longhua District, Haikou City, Hainan Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 898 6698 4599 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
海南医学院 |
||||||||||||||||||||||
|
Primary sponsor: |
Hainan Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
海南省海口市龙华区学院路3号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 3, Xueyuan Road, Longhua District, Haikou City, Hainan Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国国家自然科学基金(82360673),海南省重点研发项目(ZDYF2024SHFZ064)。 |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China (82360673), Key Research and Development Project of Hainan Provincial (ZDYF2024SHFZ064). |
||||||||||||||||||||||
|
Target disease: |
Mild cognitive imparment |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
探究数字化居家认知和体能训练对轻度认知障碍患者的可行性及有效性。 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate feasibility and effectiveness of a digital-based mild cognitive-physical exercises (Digital-Cog-PE) intervention for mild cognitively impaired individuals training at home. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)年龄在 60 岁及以上; (2)MMSE 认知评分介于24-29分之间; (3)居住在家中,并且有家属陪同一起参加本试验; (4)拥有并能独立熟练使用智能手机。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Aged 60 years older; (2) With a MMSE score between 24-29; (3) Living at home, and have a family member who are willing to join the study; (4) Have a mobile device with a built-in camera and can interact online. |
||||||||||||||||||||||
|
排除标准: |
(1)患有中度或重度认知功能障碍,或痴呆症; (2)患有精神疾病,例如重度抑郁症、焦虑症等; (3)患有重度心血管疾病、呼吸系统疾病、肝肾疾病等需要长期住院治疗的疾病; (4)患有听力和视力障碍; (5)生活不能完全自理,需要每天进行监护或看护的情况; (6)患有晚期癌症、末期疾病或其他严重疾病; (7)过去6个月内进行过大规模体育锻炼或正在进行其他干预试验。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) With moderate to severe cognitive impairment or dementia; (2) With mental illnesses such as severe depression, anxiety disorders, etc; (3) With severe cardiovascular diseases, respiratory system diseases, liver or kidney diseases that require long-term hospitalization; (4) Having hearing and visual impairments; (5) Limitation of activities in daily living skills (ADLs) and requiring daily care; (6) With terminal phase of cancer, terminal illness, or other serious illnesses; (7) Participated in major sports exercises or any other intervention study in the past 6 months. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-01-01 00:00:00至 To 2027-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-04-01 00:00:00 至 To 2025-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
非随机双盲对照试验研究。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Non-randomized, double-blind, controlled trial. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
双盲试验。 |
|
Blinding: |
Double-blind trial. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
如数据是纯科研使用,在经过正式申请,并经过课题组成员以及海南医学院同意使用的情况下,可以进行原始数据共享。原始数据共享至2027年12月31日结束。相关数据共享请联系项目负责人:丁金东dingjindong@hainmc.edu.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
For purely scientific research purposes, the original data can be shared upon request and under the approval by the research group members as well as Hainan Medical University. The time span for the original data sharing will be due on December 31, 2027. For inquiries related to data sharing, please contact the project leader: Jindong Ding Petersen via dingjindong@hainmc.edu.cn |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集将主要通过面对面访谈、纸质问卷、电子采集、社区或医院病历记录等。数据管理将严格按照海南医学院数据管理规定或其他法人资格的机构或团体组织。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection will be conducted mainly through interview, questionnaire, electronic data capture, community/hospital registers, ect. Data management will under survillance by Hainan Medical University and any other authroized entities when applicable. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |